2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$201.20-$1.00 (-0.49%)
Price as of Jul 24, 2026 7:40 PM EDT- $29.9BMarket Cap
- 53.73%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$201.20-$1.00 (-0.49%)
Earnings Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 7.34% | ||
12-Month Momentum | 50.53% | ||
3-Month Risk Adjusted Momentum | 52.47% | ||
12-Month Risk Adjusted Momentum | 158.44% |
True Yield
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.008% |
Financial Health Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |